Literature DB >> 2083199

Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activity.

C Y Hsu1, M Mohammadi, M Nathan, A Honegger, A Ullrich, J Schlessinger, D R Hurwitz.   

Abstract

We have generated a recombinant baculovirus using the high expression vector pVL941 containing the complementary DNA encoding the intracellular domain of the human epidermal growth factor receptor (EGFR-IC). Upon infection of Spodoptera frugiperda insect cells, protein tyrosine kinase-active EGFR-IC was produced. The expressed protein has a molecular weight of 61,000 and is specifically recognized by antibodies directed against peptides representing different regions of human EGFR-IC. Upon sonication of infected cells, EGFR-IC was detected in both the soluble and insoluble fractions of the cell lysate. About 20-50% of the expressed EGFR-IC was soluble. Metabolic labeling and protein analyses showed that EGFR-IC comprised 7% of newly synthesized proteins in the cytoplasmic lysate and 0.1-0.2% of the total soluble protein. We have used a three-step purification procedure (fast-Q-Sepharose and phenyl-Sepharose column chromatographies and 30% ammonium sulfate precipitation) to purify EGFR-IC to 85% purity with 15-20% recovery from the initial soluble lysate. A yield of 3-4 mg of purified EGFR-IC has been consistently produced from 20 roller bottles with 2-4 x 10(8) infected cells/bottle. The tyrosine kinase activity was retained through purification. The enzyme demonstrated much higher autophosphorylation activity in the presence of Mn2+ than Mg2+. Phosphopeptide mapping revealed the same autophosphorylation sites utilized by EGFR-IC as those identified in wild-type EGFR. EGFR-IC-catalyzed phosphorylation of either a synthetic peptide representing the major autophosphorylation site or angiotensin II showed that the baculovirus-expressed EGFR-IC exhibits similar enzymatic kinetic characteristics to the intact activated EGFR kinase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2083199

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  7 in total

1.  The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma.

Authors:  B Margolis; N Li; A Koch; M Mohammadi; D R Hurwitz; A Zilberstein; A Ullrich; T Pawson; J Schlessinger
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

2.  Stimulation by phospholipids of a protein-tyrosine-phosphatase containing two src homology 2 domains.

Authors:  Z Zhao; S H Shen; E H Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

3.  Physicochemical characterization of the cytoplasmic domain of the epidermal growth factor receptor and evidence for conformational changes associated with its activation by ammonium sulphate.

Authors:  M Gregoriou; P F Jones; J F Timms; J J Yang; S E Radford; A R Rees
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

4.  A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.

Authors:  T Moriai; M S Kobrin; C Hope; L Speck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 5.  The use of baculoviruses as expression vectors.

Authors:  I M Kidd; V C Emery
Journal:  Appl Biochem Biotechnol       Date:  1993 Aug-Sep       Impact factor: 2.926

6.  In vitro activation and inhibition of recombinant EGFR tyrosine kinase expressed in Escherichia coli.

Authors:  Jihene Elloumi-Mseddi; Karim Jellali; Sami Aifa
Journal:  ScientificWorldJournal       Date:  2013-09-25

7.  Expression and characterization of kinase-active v-erbB protein using a baculovirus vector system.

Authors:  K Morishita; M Iwamoto; K Murakami; M Kubota; S Maeda; K Toyoshima; T Yamamoto
Journal:  Jpn J Cancer Res       Date:  1992-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.